Business
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced multiple presentations at The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) 18th International Conference, and the SCWD’s Regulatory and Clinical Trials Update Regulatory Workshop, both in Rome, Italy. 18th International Conference of the Soc
About this update from Veru Inc.
[{"type":"image","alt":"Veru Inc.","displaySize":"","headline":null,"caption":"Veru Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":214,"url":"https://media.zenfs.com/en/globenewswire.com/0a5f4ba487ea74752851101a11482743"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mewu0yec4GXSU1yHV5yukA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0a5f4ba487ea74752851101a11482743","width":300,"height":214}},"lazy":false},{"type":"text","content":"MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced multiple presentations at The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD) 18th International Conference, and the SCWD’s Regulatory and Clinical Trials Update Regulatory Workshop, both in Rome, Italy.","length":459,"tagName":"p"},{"type":"text","content":"18th International Conference of the Society on Sarcopenia, Cachexia, and Wasting Disorders","length":91,"tagName":"p"},{"type":"text","content":"Program Session P: Weight loss drugs and cardiovascular healthPresenter: Mitchell Steiner, Veru Inc.’s Chairman, President & CEOSession Date: December 12, 2025Presentation Number: P3Presentation Name: The Veru ExperiencePresentation Time: 4:30 pm – 4:45 pm Central European TimePresentation Location: Hall A, A. Roma Lifestyle Hotel, Rome, Italy","length":355,"tagName":"p"},{"type":"text","content":"Program Session U: THERAPEUTICS, Novel strategies to address sarcopenia while treating obesity - round table discussionPresenter: Mitchell Steiner, Veru Inc.’s Chairman, President & CEO Session Date: December 13, 2025Presentation Number: U3Presentation Name: EnobosarmPresentation Time: 10:00 am - 10:15 am Central European TimePresentation Location: Hall A, A. Roma Lifestyle Hotel, Rome, Italy","length":405,"tagName":"p"},{"type":"text","content":"Additional information on the meeting can be found on the following website: https://society-scwd.org/annual-conference/","length":120,"tagName":"p"},{"type":"text","content":"SCWD Regulatory and Clinical Trials Update - Regulatory Workshop","length":64,"tagName":"p"},{"type":"text","content":"Presentation Name: Treatment Approaches to A...